EBMT 2020 | HCT in MDS: cell source and conditioning type

Fernando Barroso Duarte, MD, Federal University of Ceara, Clinical Hospital, Fortaleza, Brazil, discusses the influence of cell source and conditioning type on hematopoietic cell transplantation (HCT) in myelodysplastic syndromes (MDS). This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).